Bernstein Liebhard LLP Notes Growth of Federal Lipitor Lawsuits, As Cases Alleging the Statin Caused

The Firm is actively evaluating Lipitor lawsuit claims on behalf of individuals who allege their use of the cholesterol-lowering medication caused them to develop Type 2 diabetes. New York, New York (PRWEB) April 27, 2014 In just over a month, nearly 200 new Lipitor lawsuits (http://www.thelipitorlawsuit.com/ ) have been filed in a federal litigation underway in the U.S. District Court, District of South Carolina on behalf of individuals who allegedly developed Type 2 diabetes due to their use of the statin medication, Bernstein Liebhard LLP reports. According to an update issued on Apr
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories